Approval · Notice of Compliance 7983 · 2006
SUTENT: Notice of Compliance 7983
Issued May 26, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7983
- Date
- May 26, 2006
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Tyrosine kinase inhibitor
Products in this notice
Medicinal ingredients
- SUNITINIB MALATE 25 MG per CAP
- SUNITINIB MALATE 12.5 MG per CAP
- SUNITINIB MALATE 50 MG per CAP